Advertisement

Ads Placeholder
Loading...

Talphera, Inc.

TLPH•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.72
$-0.06(-7.12%)
U.S. Market opens in 0h 56m

Talphera, Inc. (TLPH) Stock Overview

Explore Talphera, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap14.8M
P/E Ratio-2.14
EPS (TTM)$-0.34
ROE-1.18%
Fundamental Analysis

AI Price Forecasts

1 Month$0.79
3 Months$1.04
1 Year Target$0.58

TLPH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Talphera, Inc. (TLPH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 39.26, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.58.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.14 and a market capitalization of 14.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-7.12%
5-Day Change
-7.04%
1-Month Change
-19.33%
3-Month Change
-37.73%
6-Month Change
-23.97%
Year-to-Date (YTD) Change
-37.73%
1-Year Change
26.74%
3-Year Change
18.41%
5-Year Change
-97.73%
All-Time (Max) Change
-99.21%

Contact Information

https://talphera.com
650 216 3500
1850 Gateway Drive, San Mateo, CA, 94404

Company Facts

130 Employees
IPO DateFeb 11, 2011
CountryUS
Actively Trading

Frequently Asked Questions